Notes to visitors
Special offer for anti-VEGF therapy for public hospital patients
Gleneagles supports a subsidy programme for patients who are following up designated ophthalmological illnesses* at public hospitals and required anti-VEGF therapy. Those patients can enjoy a special price at HK$7,650** (including doctor’s fee, medication and procedure charge) for anti-VEGF therapy at Gleneagles by referrals.
Interested patients can contact Hong Kong Health Care Alliance, which will refer eligible patients to Gleneagles. For further details, please refer to: https://bit.ly/2Vuzt0s (For enquiries/appointments, please contact Hong Kong Health Care Alliance at +852 3482 1976.)
The offer is valid until 31 December 2020 on a first-come, first-served basis.
* Designated ophthalmological illnesses include: wet age-related macular degeneration, diabetic macular edema, retinal vein occlusion and choroidal neovascularization
** T&C apply.